Author:
Teponnou Gerard A. K.,Joubert Jacques,Malan Sarel F.
Abstract
The versatile biological activities of tacrine, trolox and β-carboline derivatives make them promising lead structures for the development of multifunctional Alzheimer’s disease (AD) agents. Based on the topology of the active site of cholinesterases and other target proteins involved in the pathogenesis of AD, we have designed and synthesized tacrine-trolox and tacrine-tryptoline hybrids with various linker chain lengths. The hybrids containing the trolox moiety (8a-8d) showed moderate to high TcAChE inhibition (IC50: 17.37 - 2200 nM), eqBuChE inhibition (IC50: 3.16 – 128.82 nM) and free radical scavenging activities (IC50: 11.48 – 49.23 µM). The hybrids with longer linker chain lengths in general showed better ChE inhibitory activity. As expected, free radical scavenging activities were not significantly affected by varying linker chain lengths. The hybrid compound containing the tryptoline moiety linked with a 7 carbon spacer to tacrine (14) displayed the best AChE and BuChE inhibitory activity (IC50 = 17.37 and 3.16 nM). Docking experiments exhibited that compounds 8d and 14 were able to bind to both the CAS and PAS of TcAChE and eqBuChE, suggesting that they will be able to inhibit ChE induced Aβ aggregation. Novel multi-target agents that exhibit good ChE inhibition (8d and 14) and anti-oxidant (8d) activity were identified as suitable candidates for further investigation.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine
Reference41 articles.
1. Goedert M, Spillantini MG.
A century of Alzheimers disease.
Science
2006;
314
(5800)
: 777-81.
2. Silvestrelli G, Lanari A, Parnetti L, Tomassoni D, Amenta F.
Treatment of Alzheimers disease: from pharmacology to a better understanding of disease pathophysiology.
Mech Ageing Dev
2006;
127
(2)
: 148-57.
3. Duthey B.
Background paper 6.11: Alzheimer disease and other dementias. A Public Health Approach to Innovation, 2013, pp: 1-74.
4. Grimm OW, Hartmann T.
Recent understanding of the molecular mechanisms of alzheimer’s disease.
J Addict Res Ther
2012.
5. Skovronsky DM, Lee VM, Trojanowski JQ.
Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications.
Annu Rev Pathol
2006;
1
: 151-70.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献